Recombinant multi-species Somatostatin/SST protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Somatostatin/SST protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The hormone somatostatin has active 14 aa and 28 aa forms that are produced by alternate cleavage of the single preproprotein encoded by this gene. Somatostatin is expressed throughout the body and inhibits the release of numerous secondary hormones by binding to high-affinity G-protein-coupled somatostatin receptors. This hormone is an important regulator of the endocrine system through its interactions with pituitary growth hormone, thyroid stimulating hormone, and most hormones of the gastrointestinal tract. Somatostatin also affects rates of neurotransmission in the central nervous system and proliferation of both normal and tumorigenic cells. [provided by RefSeq, Jul 2008]
The Alternative Names of target: Growth hormone release-inhibiting factor,SMST,SOM,SRIF,SS,SS-14,SS-28,SST,SST1,Smst,Somatostatin,Sst

Target products collectionGo to Somatostatin/SST products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T95479-Ag-1/ GM-Tg-hg-T95479-Ag-2 Human Somatostatin/SST protein Human
GM-Tg-rg-T95479-Ag-1/ GM-Tg-rg-T95479-Ag-2 Rat Somatostatin/SST protein Rat
GM-Tg-mg-T95479-Ag-1/ GM-Tg-mg-T95479-Ag-2 Mouse Somatostatin/SST protein Mouse
GM-Tg-cynog-T95479-Ag-1/ GM-Tg-cynog-T95479-Ag-2 Cynomolgus/Rhesus macaque Somatostatin/SST protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T95479-Ag-1/ GM-Tg-felg-T95479-Ag-2 Feline Somatostatin/SST protein Feline
GM-Tg-cang-T95479-Ag-1/ GM-Tg-cang-T95479-Ag-2 Canine Somatostatin/SST protein Canine
GM-Tg-bovg-T95479-Ag-1/ GM-Tg-bovg-T95479-Ag-2 Bovine Somatostatin/SST protein Bovine
GM-Tg-equg-T95479-Ag-1/ GM-Tg-equg-T95479-Ag-2 Equine Somatostatin/SST protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T95479-Ag-1/ GM-Tg-hg-T95479-Ag-2; GM-Tg-rg-T95479-Ag-1/ GM-Tg-rg-T95479-Ag-2;
GM-Tg-mg-T95479-Ag-1/ GM-Tg-mg-T95479-Ag-2; GM-Tg-cynog-T95479-Ag-1/ GM-Tg-cynog-T95479-Ag-2;
GM-Tg-felg-T95479-Ag-1/ GM-Tg-felg-T95479-Ag-2; GM-Tg-cang-T95479-Ag-1/ GM-Tg-cang-T95479-Ag-2;
GM-Tg-bovg-T95479-Ag-1/ GM-Tg-bovg-T95479-Ag-2; GM-Tg-equg-T95479-Ag-1/ GM-Tg-equg-T95479-Ag-2
Products Name Somatostatin/SST protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Somatostatin/SST
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Somatostatin/SST protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.